Jeffrey A Bogart

Summary

Affiliation: SUNY Upstate Medical University
Country: USA

Publications

  1. doi request reprint Fractionated radiotherapy for high-risk patients with early-stage non-small cell lung cancer
    Jeffrey A Bogart
    Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, New York, USA
    Semin Thorac Cardiovasc Surg 22:44-52. 2010
  2. pmc Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904
    Jeffrey A Bogart
    Department of Radiation Oncology, State University of New York Upstate Medical University, 750 E Adams St, Syracuse NY 13210, USA
    J Clin Oncol 28:202-6. 2010
  3. doi request reprint Rationale for phase III trials of thoracic radiation therapy doses in limited-stage small-cell lung cancer
    Jeffrey A Bogart
    Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, NY 13210, USA
    Clin Lung Cancer 9:202-5. 2008
  4. doi request reprint Interruptions of once-daily thoracic radiotherapy do not correlate with outcomes in limited stage small cell lung cancer: analysis of CALGB phase III trial 9235
    Jeffrey A Bogart
    SUNY Upstate Medical University, Radiation Oncology Department, 750 E Adams Street, Syracuse, NY 13210, United States
    Lung Cancer 62:92-8. 2008
  5. ncbi request reprint Stereotactic body radiotherapy for poor-risk lung cancer: "more cyber, less knife?"
    Jeffrey A Bogart
    Department of Radiation Oncology, Upstate Medical University, Syracuse, NY 13210, USA
    Cancer J 13:75-7. 2007
  6. ncbi request reprint Radiation oncology research in the cancer and leukemia group B
    Jeffrey A Bogart
    Upstate Medical University, Syracuse, New York, USA
    Clin Cancer Res 12:3628s-34s. 2006
  7. ncbi request reprint Localized non-small cell lung cancer: adjuvant radiotherapy in the era of effective systemic therapy
    Jeffrey A Bogart
    Department of Radiation Oncology, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA
    Clin Cancer Res 11:5004s-5010s. 2005
  8. ncbi request reprint Dose-intensive thoracic radiation therapy for patients at high risk with early-stage non-small-cell lung cancer
    Jeffrey A Bogart
    Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, NY 13210, USA
    Clin Lung Cancer 6:350-4. 2005
  9. ncbi request reprint Early stage medically inoperable non-small cell lung cancer
    Jeffrey A Bogart
    Department of Radiation Oncology, Upstate Medical University, 750 E Adams Street, Syracuse, NY 13210, USA
    Curr Treat Options Oncol 4:81-8. 2003
  10. ncbi request reprint 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808
    Jeffrey A Bogart
    Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, NY 13210, USA
    Int J Radiat Oncol Biol Phys 59:460-8. 2004

Collaborators

Detail Information

Publications32

  1. doi request reprint Fractionated radiotherapy for high-risk patients with early-stage non-small cell lung cancer
    Jeffrey A Bogart
    Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, New York, USA
    Semin Thorac Cardiovasc Surg 22:44-52. 2010
    ..This review will focus on the potential current role of fractionated radiotherapy for high-risk patients with particular consideration of altered fractionation schemes and recent advances in treatment related technology...
  2. pmc Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904
    Jeffrey A Bogart
    Department of Radiation Oncology, State University of New York Upstate Medical University, 750 E Adams St, Syracuse NY 13210, USA
    J Clin Oncol 28:202-6. 2010
    ..The optimal treatment for medically inoperable stage I non-small-cell lung cancer (NSCLC) has not been defined...
  3. doi request reprint Rationale for phase III trials of thoracic radiation therapy doses in limited-stage small-cell lung cancer
    Jeffrey A Bogart
    Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, NY 13210, USA
    Clin Lung Cancer 9:202-5. 2008
    ..The rationale for these trials is described herein...
  4. doi request reprint Interruptions of once-daily thoracic radiotherapy do not correlate with outcomes in limited stage small cell lung cancer: analysis of CALGB phase III trial 9235
    Jeffrey A Bogart
    SUNY Upstate Medical University, Radiation Oncology Department, 750 E Adams Street, Syracuse, NY 13210, United States
    Lung Cancer 62:92-8. 2008
    ..We examined the association between TRT duration and outcomes on a prospective phase III study...
  5. ncbi request reprint Stereotactic body radiotherapy for poor-risk lung cancer: "more cyber, less knife?"
    Jeffrey A Bogart
    Department of Radiation Oncology, Upstate Medical University, Syracuse, NY 13210, USA
    Cancer J 13:75-7. 2007
  6. ncbi request reprint Radiation oncology research in the cancer and leukemia group B
    Jeffrey A Bogart
    Upstate Medical University, Syracuse, New York, USA
    Clin Cancer Res 12:3628s-34s. 2006
    ....
  7. ncbi request reprint Localized non-small cell lung cancer: adjuvant radiotherapy in the era of effective systemic therapy
    Jeffrey A Bogart
    Department of Radiation Oncology, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA
    Clin Cancer Res 11:5004s-5010s. 2005
    ..We will review the data on PORT and address critical issues in the design of trials to assess the role of modern radiotherapy in the integrated approach to management of early-stage NSCLC...
  8. ncbi request reprint Dose-intensive thoracic radiation therapy for patients at high risk with early-stage non-small-cell lung cancer
    Jeffrey A Bogart
    Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, NY 13210, USA
    Clin Lung Cancer 6:350-4. 2005
    ..Moderately accelerated single daily fractionated RT is feasible for high-risk patients with early-stage NSCLC and merits further investigation...
  9. ncbi request reprint Early stage medically inoperable non-small cell lung cancer
    Jeffrey A Bogart
    Department of Radiation Oncology, Upstate Medical University, 750 E Adams Street, Syracuse, NY 13210, USA
    Curr Treat Options Oncol 4:81-8. 2003
    ..Trials involving systemic therapy for patients with medically inoperable NSCLC should be developed...
  10. ncbi request reprint 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808
    Jeffrey A Bogart
    Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, NY 13210, USA
    Int J Radiat Oncol Biol Phys 59:460-8. 2004
    ..To prospectively evaluate the feasibility of delivering 70 Gy once-daily thoracic radiotherapy (TRT), concurrent with chemotherapy, in the treatment of limited-stage small-cell lung cancer (L-SCLC)...
  11. pmc Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and Leukemia Grou
    Joseph K Salama
    Department of Radiation Oncology, Box 3085, Duke University Medical Center, Durham, NC 27710, USA
    Int J Radiat Oncol Biol Phys 81:e269-74. 2011
    ..We conducted a secondary analysis of all patients to determine predictors of treatment-related pulmonary toxicity...
  12. pmc A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904
    Joseph K Salama
    Department of Radiation Oncology, Duke University Medical Center, Box 3085, Durham, North Carolina 27710, USA
    J Thorac Oncol 8:1043-9. 2013
    ..We pooled data of patients assigned to receive daily RT of 70 Gy from three, consecutive prospective Cancer and Leukemia Group B L-SCLC cancer trials and report the results here...
  13. doi request reprint Definitive treatment of poor-risk patients with stage I lung cancer: a single institution experience
    Michael Hsie
    SUNY Upstate Medical University, Department of Radiation Oncology, Syracuse, New York, USA
    J Thorac Oncol 4:69-73. 2009
    ..The appropriate management for this population has not been defined...
  14. ncbi request reprint Radiotherapy for the clinically negative neck in supraglottic laryngeal cancer
    Tracy E Alpert
    Department of Radiation Oncology, Upstate Medical University, Syracuse, New York 13210, USA
    Cancer J 10:335-8. 2004
    ..We report on our series of patients who received radiotherapy as sole treatment to the clinically negative neck, either to the bilateral neck for N0 disease or to the contralateral neck for ipsilateral lymphatic involvement...
  15. doi request reprint Stereotactic body radiotherapy in patients with stage I non-small-cell lung cancer aged 75 years and older: retrospective results from a multicenter consortium
    Michael A Samuels
    Department of Radiation Oncology, University of Miami, Miller School of Medicine, Miami, FL 33136, USA
    Clin Lung Cancer 14:446-51. 2013
    ..This study was a retrospective analysis of elderly patients treated with stereotactic body radiotherapy (SBRT) in the setting of a multi-institutional consortium...
  16. doi request reprint Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials
    John W Powell
    Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, NY 13210, USA
    Lancet Oncol 10:885-94. 2009
    ..Ongoing challenges are presented and prospective data are emphasised...
  17. ncbi request reprint A randomized phase II study of radiation therapy, pemetrexed, and carboplatin with or without cetuximab in stage III non-small-cell lung cancer
    Jeffrey A Bogart
    Department of Radiation Oncology, Upstate Medical University, Syracuse, NY, USA
    Clin Lung Cancer 7:285-7. 2006
  18. ncbi request reprint Gamma knife surgery for trigeminal neuralgia: improved initial response with two isocenters and increasing dose
    Tracy E Alpert
    Department of Radiation Oncology and Neurosurgery, Upstate Medical University, Syracuse, New York 13210, USA
    J Neurosurg 102:185-8. 2005
    ..The authors sought to evaluate the initial response of trigeminal neuralgia (TN) to gamma knife surgery (GKS) based on the number of shots delivered and radiation dose...
  19. ncbi request reprint Radiotherapy for moderate-to-severe Graves' ophthalmopathy: improved outcomes with early treatment
    Tracy E Alpert
    Department of Radiation Oncology, Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA
    Cancer J 9:472-5. 2003
    ..The purpose of this review is to quantify the response to radiotherapy delivered early in the active inflammatory phase of moderate-to-severe Graves' ophthalmopathy...
  20. doi request reprint Radiotherapy for stage III non-small-cell lung carcinoma in the elderly (age ≥ 70 years)
    Paul D Aridgides
    Department of Radiation Oncology, SUNY Upstate Medical University, Syracuse, NY Electronic address
    Clin Lung Cancer 14:674-9. 2013
    ..This study analyzed radiotherapy treatment delivery and outcomes at our institution according to elderly (≥ 70 years old) or younger (< 70 years) age...
  21. ncbi request reprint Successful treatment of spindle cell sarcoma of the sella turcica. Case report
    Tracy E Alpert
    Department of Radiation Oncology, State University of New York Upstate Medical University, Syracuse, New York 13210, USA
    J Neurosurg 97:438-40. 2002
    ..After 24 months of follow up, the patient continues to show no evidence of disease...
  22. doi request reprint Radiation therapy-related toxicity (including pneumonitis and fibrosis)
    Rahul R Chopra
    Department of Radiation Oncology, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA
    Emerg Med Clin North Am 27:293-310. 2009
    ..This article is designed to acquaint emergency medicine physicians with common, expected, and potential acute and late complications of RT...
  23. ncbi request reprint Complications from computed tomography-guided core needle biopsy for patients receiving stereotactic body radiation therapy for early-stage lesions of the lung
    Varun K Chowdhry
    State University of New York Upstate Medical University, Syracuse, NY Electronic address
    Clin Lung Cancer 15:302-6. 2014
    ..Nevertheless, there is limited information regarding biopsy-related complication rates in high-risk patients with early-stage NSCLC who are treated with SBRT...
  24. ncbi request reprint Radiation therapy-related toxicity (including pneumonitis and fibrosis)
    Rahul R Chopra
    Department of Radiation Oncology, State University of New York Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA
    Hematol Oncol Clin North Am 24:625-42. 2010
    ..This article is designed to acquaint the reader with common, expected, and potential acute and late complications of RT...
  25. ncbi request reprint Autopsy evaluation of a prostate cancer case treated with brachytherapy
    Anna Shapiro
    Department of Radiation Oncology, Upstate Medical University, Syracuse, NY 13210, USA
    Anticancer Res 28:3909-12. 2008
    ..It is crucial that this uncertainty is kept in mind in making further management decisions in patients who have undergone radiation therapy and follow-up biopsy of the prostate gland...
  26. doi request reprint Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105
    Mark A Socinski
    Lineberger Comprehensive Cancer Center, University of North Carolina Chapel Hill, NC 27599, USA
    J Clin Oncol 26:2457-63. 2008
    ..To evaluate 74 Gy thoracic radiation therapy (TRT) with induction and concurrent chemotherapy in stage IIIA/B non-small-cell lung cancer (NSCLC)...
  27. ncbi request reprint Limited-stage small-cell lung cancer: the current status of combined-modality therapy
    Mark A Socinski
    Multidisciplinary Thoracic Oncology Program, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
    J Clin Oncol 25:4137-45. 2007
    ..LS-SCLC has been a model cancer in terms of the potential benefit of combined chemoradiotherapy strategies in improving patient outcomes...
  28. ncbi request reprint Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002
    Antonius A Miller
    Comprehensive Cancer Center, Wake Forest University, Winston Salem, North Carolina, USA
    J Thorac Oncol 2:645-51. 2007
    ....
  29. ncbi request reprint Definitive radiotherapy for stage I non-small cell lung cancer: ain't nothing like the real thing?
    Jeffrey A Bogart
    J Thorac Oncol 1:763-5. 2006
  30. ncbi request reprint Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement
    Thomas J Lynch
    Division of Hematology Oncology and Dana Farber Partners Cancer Care, Massachusetts General Hospital, 100 Blossom Street, Boston, MA 02114, USA
    Clin Cancer Res 11:4981s-4983s. 2005
  31. ncbi request reprint Hypofractionated radiotherapy for advanced non-small-cell lung cancer: is the LINAC half full?
    Jeffrey A Bogart
    J Clin Oncol 22:765-8. 2004
  32. ncbi request reprint Hypofractionated irradiation for non-small cell lung cancer
    Raymond P Abratt
    Department of Radiation Medicine, Division of Radiation Oncology, Groote Schuur Hospital and University of Cape Town, Observatory 7925, Cape Town, South Africa
    Lung Cancer 36:225-33. 2002
    ..However, more advanced tumours may be treated with hypofractionation to lower total doses to achieve palliation and a modest degree of survival benefit...